EUVIMEDEUVIMED entdecken
Übersichtsarbeit

The Future of Gene Therapy: A Review of In Vivo and Ex Vivo Delivery Methods for Genome Editing-Based Therapies

Olga Volodina, Svetlana Smirnikhina

Molecular Biotechnology · 2025-02 · 67 (2) · 425-437

DOI: 10.1007/s12033-024-01070-4 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Molecular Biotechnology, online erschienen am 16.02.2024. Verfasst von Olga Volodina und 1 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Genome Editing, Research Centre for Medical Genetics, Moscow, 115522, Russia. volodold@gmail.com. Hauptthemen laut MEDLINE: Gene Editing, Genetic Therapy, Gene Transfer Techniques. Die Arbeit wurde bisher 47-mal zitiert (Crossref) und nennt 59 Literaturangaben. Gefördert von: Ministry of Science and Higher Education of the Russian Federation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The development of gene therapy based on genome editing has opened up new possibilities for the treatment of human genetic disorders. This field has developed rapidly over the past few decades, some genome editing-based therapies are already in phase 3 clinical trials. However, there are several challenges to be addressed before widespread adoption of gene editing therapy becomes possible. The main obstacles in the development of such therapy are safety and efficiency, so one of the biggest issues is the delivery of genetic constructs to patient cells. Approaches in genetic cargo delivery divide into ex vivo and in vivo, which are suitable for different cases. The ex vivo approach is mainly used to edit blood cells, improve cancer therapy, and treat infectious diseases. To edit cells in organs researches choose in vivo approach. For each approach, there is a fairly large set of methods, but, unfortunately, these methods are not universal in their effectiveness and safety. The focus of this article is to discuss the current status of in vivo and ex vivo delivery methods used in genome editing-based therapy. We will discuss the main methods employed in these approaches and their applications in current gene editing treatments under development.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gene EditingGenetic TherapyGene Transfer TechniquesHumansAnimalsCRISPR-Cas SystemsNeoplasmsGenetic Vectors

Stichwörter der Autor:innen

Delivery methodsEx vivoGene editingGene therapyIn vivo

Autor:innen und Institutionen

  • Laboratory of Genome Editing, Research Centre for Medical Genetics, Moscow, 115522, Russia. volodold@gmail.com.
  • Laboratory of Genome Editing, Research Centre for Medical Genetics, Moscow, 115522, Russia.

Förderung

  • Ministry of Science and Higher Education of the Russian Federation

Zitieren

APA

Volodina, O., & Smirnikhina, S. (2025). The Future of Gene Therapy: A Review of In Vivo and Ex Vivo Delivery Methods for Genome Editing-Based Therapies. Molecular Biotechnology, 67(2), 425-437. https://doi.org/10.1007/s12033-024-01070-4

Vancouver

Volodina O, Smirnikhina S. The Future of Gene Therapy: A Review of In Vivo and Ex Vivo Delivery Methods for Genome Editing-Based Therapies. Molecular Biotechnology. 2025;67(2):425-437. doi:10.1007/s12033-024-01070-4

BibTeX
@article{Volodina2025,
  author = {Volodina, Olga and Smirnikhina, Svetlana},
  title = {The Future of Gene Therapy: A Review of In Vivo and Ex Vivo Delivery Methods for Genome Editing-Based Therapies},
  journal = {Molecular Biotechnology},
  year = {2025},
  volume = {67},
  number = {2},
  pages = {425--437},
  doi = {10.1007/s12033-024-01070-4}
}
Kostenlos starten →